Literature DB >> 15988033

Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.

Huifang M Zhang1, Ji Yuan, Paul Cheung, David Chau, Brian W Wong, Bruce M McManus, Decheng Yang.   

Abstract

Gamma interferon-inducible protein 10 (IP10) is a member of the CXC family of chemokines. By differential mRNA display, we have demonstrated the upregulation of IP10 in coxsackievirus B3 (CVB3)-infected mouse hearts. Functional characterization of the IP10 gene in IP10-transfected Tet-On HeLa cells has found that IP10 induced cell apoptosis and inhibited viral replication. In the characterization of the IP10-induced apoptotic pathway, we found that overexpression of IP10 upregulated p53 and resulted in altered expression of p53-responsive genes such as the p21Cip1, p27kip1, NF-kappaB, Bax, and PUMA genes and the mitochondrial translocation of Bax. However, transduction of the IP10 cells with adenovirus expressing dominant negative p53 not only ablated p53-triggered gene expression but also abolished IP10-induced apoptosis and restored CVB3 replication to the control levels. These data suggest a novel mechanism by which IP10 inhibits viral replication through the induction of host cell death via a p53-mediated apoptotic pathway. We also found that constantly high-level expression of p53 in these tumor cells is attributed to the IP10-induced suppression of human papillomavirus E6 and E7 oncogene expression. Taken together, these data reveal not only a previously unrecognized link between chemokine IP10 and p53 in antiviral defense but also a mechanism by which IP10 inhibits tumor cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988033      PMCID: PMC1168823          DOI: 10.1128/MCB.25.14.6247-6258.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

Review 1.  The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.

Authors:  A D'Ambrosio; G Patti; A Manzoli; G Sinagra; A Di Lenarda; F Silvestri; G Di Sciascio
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

2.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

Review 3.  Control of interferon signaling in human papillomavirus infection.

Authors:  A E Koromilas; S Li; G Matlashewski
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

4.  Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.

Authors:  M Melter; A Exeni; M E Reinders; J C Fang; G McMahon; P Ganz; W W Hancock; D M Briscoe
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

Review 5.  Molecular mechanisms of apoptosis in the cardiac myocyte.

Authors:  N H Bishopric; P Andreka; T Slepak; K A Webster
Journal:  Curr Opin Pharmacol       Date:  2001-04       Impact factor: 5.547

6.  Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration.

Authors:  L G Koniaris; T Zimmers-Koniaris; E C Hsiao; K Chavin; J V Sitzmann; J M Farber
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

7.  Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides.

Authors:  A Wang; P K Cheung; H Zhang; C M Carthy; L Bohunek; J E Wilson; B M McManus; D Yang
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Authors:  M Loetscher; B Gerber; P Loetscher; S A Jones; L Piali; I Clark-Lewis; M Baggiolini; B Moser
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

9.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

10.  Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.

Authors:  A J Raffo; A L Kim; R L Fine
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

View more
  26 in total

1.  p53 represses class switch recombination to IgG2a through its antioxidant function.

Authors:  Jeroen E J Guikema; Carol E Schrader; Michael H Brodsky; Erin K Linehan; Adam Richards; Nahla El Falaky; Daniel H Li; Hayla K Sluss; Eva Szomolanyi-Tsuda; Janet Stavnezer
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

2.  CXCL10 enhances radiotherapy effects in HeLa cells through cell cycle redistribution.

Authors:  Ling-Lin Yang; Bi-Qiong Wang; Lan-Lan Chen; Hui-Qun Luo; Jing-Bo Wu
Journal:  Oncol Lett       Date:  2011-11-04       Impact factor: 2.967

3.  Central role of ULK1 in type I interferon signaling.

Authors:  Diana Saleiro; Swarna Mehrotra; Barbara Kroczynska; Elspeth M Beauchamp; Pawel Lisowski; Beata Majchrzak-Kita; Tushar D Bhagat; Brady L Stein; Brandon McMahon; Jessica K Altman; Ewa M Kosciuczuk; Darren P Baker; Chunfa Jie; Nadereh Jafari; Craig B Thompson; Ross L Levine; Eleanor N Fish; Amit K Verma; Leonidas C Platanias
Journal:  Cell Rep       Date:  2015-04-16       Impact factor: 9.423

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

6.  Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil.

Authors:  Jing Gao; Jin Gao; Lan Qian; Xia Wang; Mingyuan Wu; Yang Zhang; Hao Ye; Shunying Zhu; Yan Yu; Wei Han
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

7.  Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.

Authors:  Surinder Kaur; Antonella Sassano; Ajith M Joseph; Beata Majchrzak-Kita; Elizabeth A Eklund; Amit Verma; Saskia M Brachmann; Eleanor N Fish; Leonidas C Platanias
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses.

Authors:  Yan Yue; Jun Gui; Wenqing Ai; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

9.  Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals.

Authors:  Barbara Kroczynska; Surinder Kaur; Efstratios Katsoulidis; Beata Majchrzak-Kita; Antonella Sassano; Sara C Kozma; Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

10.  Role of the Akt pathway in mRNA translation of interferon-stimulated genes.

Authors:  Surinder Kaur; Antonella Sassano; Blazej Dolniak; Sonali Joshi; Beata Majchrzak-Kita; Darren P Baker; Nissim Hay; Eleanor N Fish; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.